Showing results (191-200 of 205) with videos related to
Sort By:
Pageof 21
Journal for Immunotherapy of Cancer|October 7, 2020
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8Markus Hecht, Antoniu Oreste Gostian, Markus Eckstein, et al.Cancers|April 30, 2021
Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck CancerSabine Semrau, Antoniu-Oreste Gostian, Maximilian Traxdorf, et al.Neoplasia (New York, N.Y.)|January 17, 2024
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trialMarkus Hecht, Benjamin Frey, Udo S Gaipl, et al.Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 13, 2021
Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in GermanyDavid Krug, Markus Hecht, Nadja Ebert, et al.Scientific Reports|May 17, 2025
A self-supervised multimodal deep learning approach to differentiate post-radiotherapy progression from pseudoprogression in glioblastomaAhmed Gomaa, Yixing Huang, Pluvio Stephan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2025
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 TrialRainer Fietkau, Michael Ghadimi, Robert Grützmann, et al.Journal for Immunotherapy of Cancer|January 26, 2022
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancerMarkus Hecht, Markus Eckstein, Sandra Rutzner, et al.Zeitschrift Fur Medizinische Physik|November 30, 2025
Multicenter comparison of different total body irradiation techniques - Results from the DGMP Working group large-field irradiation techniquesMaya Shariff, Falk Tillner, Oliver Schramm, et al.Journal of Neuro-Oncology|May 1, 2025
Reirradiation for recurrent glioblastoma: the significance of the residual tumor volumeSina Mansoorian, Manuel Schmidt, Thomas Weissmann, et al.Journal for Immunotherapy of Cancer|November 14, 2020
Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cellsRoger Sun, Nora Sundahl, Markus Hecht, et al.Pageof 21